Analysing survival in the presence of an auxiliary variable
- 15 September 1994
- journal article
- clinical trial
- Published by Wiley in Statistics in Medicine
- Vol. 13 (17), 1747-1754
- https://doi.org/10.1002/sim.4780131706
Abstract
A primary endpoint of AIDS trials is the length of survival. Often there is auxiliary information available on measures of disease progression, which significantly alter the risk of mortality. This paper explores the use of this information in obtaining a refined estimate of survival, and a test based on this estimate. The methods are applied to an AIDS clinical trial, and results of simulations are provided which compare the approach to standard methods for survival analysis.Keywords
This publication has 16 references indexed in Scilit:
- A kernel method for incorporating information on disease progression in the analysis of survivalBiometrika, 1994
- Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids researchStatistics in Medicine, 1994
- A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- The control of confounding by intermediate variablesStatistics in Medicine, 1989
- Supremum Versions of the Log-Rank and Generalized Wilcoxon StatisticsJournal of the American Statistical Association, 1987
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effectMathematical Modelling, 1986
- Some test statistics for use in multistate survival analysisBiometrika, 1983